Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Yubo International Biotech's operating income for the twelve months ending Jun 30, 2026 was -$1.12M. For fiscal 2026 it was -$1.19M. The highest annual figure on record is -$29.00K in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | -$1.19M | – |
| FY2025 | Dec 31, 2024 | -$1.77M | – |
| FY2024 | Dec 31, 2023 | -$1.19M | – |
| FY2023 | Dec 31, 2022 | -$1.21M | – |
| FY2022 | Dec 31, 2021 | -$1.54M | – |
| FY2020 | Feb 29, 2020 | -$29.00K | – |
| FY2019 | Feb 28, 2019 | -$48.00K | – |
| FY2018 | Feb 28, 2018 | -$58.00K | – |
| FY2017 | Feb 28, 2017 | -$149.00K | – |
| FY2016 | Feb 29, 2016 | -$63.00K | – |
| FY2015 | Feb 28, 2015 | -$58.00K | – |
| FY2014 | Feb 28, 2014 | -$55.00K | – |
| FY2013 | Feb 28, 2013 | -$60.00K | – |
| FY2012 | Feb 29, 2012 | -$47.00K | – |
| FY2011 | Feb 28, 2011 | -$80.00K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jun 30, 2026 | -$238.86K | – |
| Q1 FY2027CQ1 2026 | Mar 31, 2026 | -$289.27K | – |
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | -$285.47K | – |
| Q3 FY2026CQ3 2025 | Sep 30, 2025 | -$310.13K | – |
| Q2 FY2026CQ2 2025 | Jun 30, 2025 | -$249.70K | – |
| Q1 FY2026CQ1 2025 | Mar 31, 2025 | -$467.30K | – |
| Q4 FY2025CQ4 2024 | Dec 31, 2024 | -$357.30K | – |
| Q3 FY2025CQ3 2024 | Sep 30, 2024 | -$532.76K | -8394.6% |
| Q2 FY2025CQ2 2024 | Jun 30, 2024 | -$470.44K | – |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | -$409.42K | – |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | -$517.32K | -599.9% |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | $6.42K | – |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | -$367.28K | – |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | -$316.53K | – |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | $103.48K | – |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | -$238.27K | – |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | -$491.50K | – |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | -$578.94K | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | -$388.20K | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | -$346.01K | – |
| Q2 FY2022CQ2 2021 | Jun 30, 2021 | -$370.09K | – |
| Q1 FY2022CQ1 2021 | Mar 31, 2021 | -$438.57K | – |
| Q4 FY2020CQ1 2020 | Feb 29, 2020 | -$4.00K | – |
| Q3 FY2020CQ4 2019 | Nov 30, 2019 | -$8.00K | – |
| Q2 FY2020CQ3 2019 | Aug 31, 2019 | -$8.00K | – |
| Q1 FY2020CQ2 2019 | May 31, 2019 | -$8.00K | – |
| Q4 FY2019CQ1 2019 | Feb 28, 2019 | -$8.00K | -200.0% |
| Q3 FY2019CQ4 2018 | Nov 30, 2018 | -$7.00K | – |
| Q2 FY2019CQ3 2018 | Aug 31, 2018 | -$12.00K | – |
| Q1 FY2019CQ2 2018 | May 31, 2018 | -$21.00K | – |
| Q4 FY2018CQ1 2018 | Feb 28, 2018 | $8.00K | – |
| Q3 FY2018CQ4 2017 | Nov 30, 2017 | -$22.00K | – |
| Q2 FY2018CQ3 2017 | Aug 31, 2017 | -$22.00K | – |
| Q1 FY2018CQ2 2017 | May 31, 2017 | -$23.00K | – |
| Q4 FY2017CQ1 2017 | Feb 28, 2017 | -$96.00K | – |
| Q3 FY2017CQ4 2016 | Nov 30, 2016 | -$24.00K | – |
| Q2 FY2017CQ3 2016 | Aug 31, 2016 | -$14.00K | – |
| Q1 FY2017CQ2 2016 | May 31, 2016 | -$16.00K | – |
| Q4 FY2016CQ1 2016 | Feb 29, 2016 | -$13.00K | – |
| Q3 FY2016CQ4 2015 | Nov 30, 2015 | -$14.00K | – |
See a number that looks wrong?